Analytical Data
-
基因名
IFN-gamma
-
简介
IFN-gamma Protein, human activates STAT signaling pathway and affects gene regulation. IFN-gamma Protein, human activates effector immune cells and enhances antigen presentation. IFN-gamma Protein, human also regulates the hematopoietic stem cells development. IFN-gamma Protein, human is the recombinant human-derived IFN-gamma Protein, expressed by E. coli.
- Application
-
别名
rHuIFN-γ; IFNG; IFN-gamma; Interferon gamma
-
种属
Human
-
表达系统
E. coli
-
标签
Tag Free
-
纯度
Greater than 95% as determined by reducing SDS-PAGE.
-
蛋白编号
P01579
-
表达区间
Q24-Q166
-
蛋白长度
Full Length of Mature Protein
-
分子量
16-18 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Interferon-gamma (IFN-γ) is a crucial cytokine in the immune system, primarily produced by T cells and natural killer (NK) cells. It plays a vital role in modulating immune responses, enhancing the anticancer and antiviral activity of immune cells, and promoting antigen presentation. Given its importance in various immune-related disorders, including autoimmune diseases, cancer, and infections, recombinant IFN-γ has been extensively researched for therapeutic applications. Historically, IFN-γ was first identified for its ability to inhibit viral replication and regulate the expression of major histocompatibility complex (MHC) molecules. Subsequent studies have demonstrated its potential in enhancing the immune response against tumors and pathogens, making it a candidate for treatment in diseases such as chronic granulomatous disease and certain types of cancer. Researchers have focused on developing stable recombinant proteins that mimic natural IFN-γ to harness its therapeutic benefits. Advanced biotechnological methods, including genetic engineering and expression systems, have been employed to produce IFN-γ in sufficient quantities for clinical use. Ongoing investigations are aimed at understanding its mechanisms of action, optimizing its production, and developing novel delivery methods, further underscoring the significance of IFN-γ in immunotherapy and vaccine development. The continued exploration of IFN-γ and its applications represents a promising frontier in both basic research and clinical practices within the field of immunology.
